The relationship between the inflammatory markers and arterial distensibility in patients with sarcoidosis

Amaç: Sarkoidoz, etyolojisi bilinmeyen, organlarda nonkazeöz granulomlarla karakterize bir multisistem hastalıktır. Bu çalışmanın amacı, kronik inflamasyon arteriyel fonksiyonları bozabilir ve sarkoidozlu hastalarda arteriyel nabız dalga hızında (NDH) artışa yol açabilir hipotezini araştırmaktır. Hastalar ve Yöntemler: Çalışmaya toplam 19 sarkoidozlu hasta (12 kadın, 7 erkek) ve benzer cinsiyette 19 sağlıklı kişiden oluşan kontrol grubu dahil edildi. Aortik NDH, otomatik online nabız dalga kaydına ve nabız dalga hızının otomatik hesaplanmasına imkan veren Complior cihazı (Fransa) kullanılarak hesaplandı. Bulgular: NDH, glükoz, LDL kolesterol, ürik asit, yüksek duyarlıklı C-reaktif protein ve eritrosit sedimentasyon hızı sarkoidozlu hasta grubunda kontrol grubuna göre daha yüksekti (sırası ile p=0.04, p=0.03, p=0.02, p=0.008, p=0.04, p=0.005). NDH ile yaş (p=0.001, r=0.52), vücut kitle indeksi (p=0.01, r=0.40), sistolik kan basıncı (p

Sarkoidozlu hastalarda inflamasyon belirteçleri ile arteriyel genişleyebilirlik arasındaki ilişki

Objectives: Sarcoidosis is a multisystem disorder of unknown etiology and is characterized by noncaseating granulomas in organs. The purpose of this study was to test the hypothesis that chronic inflammation may impair arterial function and lead to an increase in arterial pulse wave velocity (PWV) in patients with sarcoidosis. Patients and Methods: We recruited 19 patients (12 women, 7 men) with sarcoidosis, and 19 sex-matched healthy controls. Aortic PWV was determined by using an automatic device, the Complior Colson (France), which allowed on-line pulse wave recording and automatic calculation of PWV. Results: The PWV, glucose, LDL cholesterol, uric acid, high-sensitivity C-reactive protein and erythrocyte sedimentation rate were higher in patients with sarcoidosis than in control subjects (p=0.04, p=0.03, p=0.02, p=0.008, p=0.04, p=0.005, respectively). We found significant correlation between PWV and age (p=0.001, r=0.52), body mass index (p=0.01, r=0.40), systolic blood pressure (p<0.001, r=0.71), diastolic blood pressure (p<0.001, r=0.63), mean blood pressure (p<0.001, r=0.68), pulse pressure (p<0.001, r=0.63), pulse transit time (p<0.001, r=-0.90), total cholesterol (p=0.002, r=0.47) and LDL cholesterol (p=0.001, r=0.51). Conclusion: The carotid-femoral (aortic) PWV was higher in patients with sarcoidosis than in control subjects. PWV is influenced by total cholesterol, LDL cholesterol, age, body-mass index and blood pressure level.

___

  • 1) Porzeziñska M, Drozdowski J, Po³awska K, Wolska-Goszka L, Cynowska B, S³omiñski JM. Isolated sarcoidosis of upper respiratory tract--a description of 2 cases. Pneumonol Alergol Pol 2008;76:276-80. [Abstract]
  • 2) Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:149-73.
  • 3) Gupta R, Murray PI. Chronic non-infectious uveitis in the elderly: epidemiology, pathophysiology and management. Drugs Aging 2006;23:535-58.
  • 4) Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736-55.
  • 5) Müller-Quernheim J. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J 1998;12:716-38.
  • 6) Takemura T, Shishiba T, Akiyama O, Oritsu M, Matsui Y, Eishi Y. Vascular involvement in cutaneous sarcoidosis. Pathol Int 1997;47:84-9.
  • 7) Gran JT. Multiorgan sarcoidosis presenting with symmetric polyarthralgia, cutaneous vasculitis, and sicca symptoms. Scand J Rheumatol 1997;26:225-6.
  • 8) Munro JM, Cotran RS. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest 1988;58:249-61.
  • 9) Cohn JN. Arterial compliance to stratify cardiovascular risk: more precision in therapeutic decision making. Am J Hypertens 2001;14:258S-263S.
  • 10) London GM, Marchais SJ, Guerin AP, Metivier F, Adda H, Pannier B. Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients. Kidney Int Suppl 2003;84:S88-93.
  • 11) Yildiz M, Masatlioglu S, Seymen P, Aytac E, Sahin B, Seymen HO. The carotid-femoral (aortic) pulse wave velocity as a marker of arterial stiffness in familial Mediterranean fever. Can J Cardiol 2006;22:1127-31.
  • 12) Imura T, Yamamoto K, Kanamori K, Mikami T, Yasuda H. Non-invasive ultrasonic measurement of the elastic properties of the human abdominal aorta. Cardiovasc Res 1986;20:208-14.
  • 13) Wong M, Toh L, Wilson A, Rowley K, Karschimkus C, Prior D, et al. Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation. Arthritis Rheum 2003;48:81-9.
  • 14) Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995;26:485-90.
  • 15) Wilkinson IB, Webb DJ, Cockcroft JR. Aortic pulse-wave velocity. Lancet 1999;354:1996-7.
  • 16) Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997;336:1224-34.
  • 17) Muscari A, Nanni Costa A, Bozzoli C, Puddu GM, Iannelli S, Vallar G, et al. Immunologic changes in circulating leukocytes in the presence of atherosclerotic disease. Recenti Prog Med 1994;85:166-73.
  • 18) Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001;103:1813-8.
  • 19) Andoh N, Minami J, Ishimitsu T, Ohrui M, Matsuoka H. Relationship between markers of inflammation and brachial-ankle pulse wave velocity in Japanese men. Int Heart J 2006;47:409-20.
  • 20) Kampus P, Muda P, Kals J, Ristimäe T, Fischer K, Teesalu R, et al. The relationship between inflammation and arterial stiffness in patients with essential hypertension. Int J Cardiol 2006;112:46-51.
  • 21) Vlachopoulos C, Dima I, Aznaouridis K, Vasiliadou C, Ioakeimidis N, Aggeli C, et al. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation 2005;112:2193-200.
  • 22) Achimastos AD, Efstathiou SP, Christoforatos T, Panagiotou TN, Stergiou GS, Mountokalakis TD. Arterial stiffness: determinants and relationship to the metabolic syndrome. Angiology 2007;58:11-20.
  • 23) Wilkinson IB, Prasad K, Hall IR, Thomas A, MacCallum H, Webb DJ, et al. Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol 2002;39:1005-11.
  • 24) Vermeersch SJ, Rietzschel ER, De Buyzere ML, De Bacquer D, De Backer G, Van Bortel LM, et al. Age and gender related patterns in carotid-femoral PWV and carotid and femoral stiffness in a large healthy, middle-aged population. J Hypertens 2008;26:1411-9.
  • 25) Safar ME. Pulse pressure in essential hypertension: clinical and therapeutical implications. J Hypertens 1989;7:769-76.
  • 26) Laurent S, Kingwell B, Bank A, Weber M, Struijker-Boudier H. Clinical applications of arterial stiffness: therapeutics and pharmacology. Am J Hypertens 2002;15:453-8.
  • 27) Cheng LT, Chen HM, Tang LJ, Tang W, Huang HY, Gu Y, et al. The study of aortic stiffness in different hypertension subtypes in dialysis patients. Hypertens Res 2008;31:593-9.
  • 28) Armentano RL, Barra JG, Levenson J, Simon A, Pichel RH. Arterial wall mechanics in conscious dogs. Assessment of viscous, inertial, and elastic moduli to characterize aortic wall behavior. Circ Res 1995;76:468-78.
  • 29) Anuurad E, Shiwaku K, Nogi A, Kitajima K, Enkhmaa B, Shimono K, et al. The new BMI criteria for asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers. J Occup Health 2003;45:335-43.
Trakya Üniversitesi Tıp Fakültesi Dergisi-Cover
  • ISSN: 1301-3149
  • Yayın Aralığı: Yılda 2 Sayı
  • Başlangıç: 2018
  • Yayıncı: -
Sayıdaki Diğer Makaleler

The relationship between the inflammatory markers and arterial distensibility in patients with sarcoidosis

HURİYE BALCI, Sipahi Sevtap DEMİRKÖK, Mustafa YILDIZ, GÖKHAN METİN, Münire HACIBEKİROĞLU, GÖNÜL ŞİMŞEK

Göğüs duvarı fibröz displazili olguların tanısı ve uzun dönem takibi

Orhan YÜCEL, BURÇİN ÇELİK, Hasan ÇAYLAK, Kuthan KAVAKLI, Alper GÖZÜBÜYÜK, Sedat GÜRKÖK, MEHMET DAKAK, Ersin SAPMAZ, Sezai ÇUBUK, Onur GENÇ

Comparison of the knowledge and attitudes of midwives about breastfeeding with breastfeeding behaviors of the mothers they provide counseling

Sedat DURAN, RIDVAN DURAN, E. Melih ŞAHİN, HAMDİ NEZİH DAĞDEVİREN, Ahmet GÜZEL

Lipoma of the large intestine: A clinicopathological review of six cases

Nazif ERKAN, Cemil ÇALIŞKAN, Enver VARDAR, Cengiz YILMAZ, Mustafa KORKUT

Pregnancy-associated aplastic anemia: Case report

Ahmet KALE, Umur KUYUMCUOĞLU, Hançer FATMANUR

The effect of regular training with vitamin e supplementation on the thioredoxine system in rats

GÖKHAN METİN, MİNE KUCUR, FERRUH KEMAL İŞMAN, Mehmet ALTAN, MURAT MENGİ, Lütfi ÇAKAR, Koray GÜMÜŞTAŞ, Emel ZENGİN

The effect of nicotine treatment on propofol injection pain

Veysel ERDEN, Gökçen BAŞARANOĞLU, Kerem ERKALPİ, Zehra YANGIN, Hamdi DELATİOĞLU, M.Gökhan TEKER, Leyla SAİTOĞLU

Robbery-related homicides of taxi drivers in three big cities of Turkey between 1996 and 2006

Mehmet Sunay YAVUZ, MAHMUT AŞIRDİZER, NERGİS CANTÜRK, Şenal Berna ERASLAN, Zafer KARADENİZ

A rare case of angiomyxolipoma: Differential diagnosis from other vascular and myxoid tumors

Ufuk USTA, Öz Fulya PUYAN, Nuray CAN, ALİ KEMAL KUTLU, Atakan SEZER

Iatrogenic cushing syndrome due to topical steroid administration in an infant

FİLİZ TÜTÜNCÜLER KÖKENLİ, Mustafa TEKİN, Demet BALCI, Özlem ŞAHALOĞLU